Ramy Farid, Ph.D. - President and CEO, Board Member
Robert Abel, Ph.D. - Vice President, Scientific Development
Cony D’Cruz - Executive Vice President, Business Development
Volker Eyrich, Ph.D. - Vice President, Professional Solutions
Leah Frye, Ph.D. - Vice President, Drug Discovery Group
Mathew D. Halls, Ph.D. - Vice President, Materials Science
Shi-Yi Liu, Ph.D. - Senior Vice President of Marketing
Shunichi Ozawa - Vice President, Japan Operations
Murco Ringnalda, Ph.D. - Chief Financial Officer
Yvonne Tran - Vice President & General Counsel
Dr. Jörg Weiser - Executive Vice President & Managing Director
Ramy Farid, President and CEO, and member of the Board of Directors, joined Schrödinger in 2002. Dr. Farid also serves on the Boards of Nimbus Therapeutics, a biotech company he helped found with Atlas Ventures, and Morphic Therapeutic, another biotech company co-founded by Schrödinger. Prior to joining Schrödinger, Dr. Farid was an Assistant Professor in the Chemistry Department at Rutgers University. He was an NIH Postdoctoral Fellow in the Department of Biochemistry and Biophysics at the University of Pennsylvania and received his Ph.D. in Chemistry from Caltech.
Robert Abel, Vice President of Scientific Development, is responsible for leading efforts to further improve induced-fit docking, free energy perturbation theory, physics-based affinity scoring, and protein structure prediction; as well as supervising the Schrödinger R&D portfolio. Robert obtained his PhD from Columbia University for his work with Professor Richard Friesner on methods to quantify the role of the solvent in protein-ligand binding. He has also been awarded NSF and DHS research fellowships; published on a variety of topics including protein-ligand binding, protein dynamics, protein structure prediction, energy function development, and fluid thermodynamics; served as a referee for several prestigious journals; and co-authored multiple patent applications. Since joining Schrödinger in 2009, Robert has advanced through a number of roles to his current position.
Cony D’Cruz, Executive Vice President of Business Development, was previously President of Proteros US, Inc. and Chief Business Officer at Proteros responsible for all commercial activities. Prior to Proteros Cony was Senior Vice President, Business Development, North America for Evotec AG Hamburg for over nine years and was responsible for managing all commercial activities of Evotec in North America. In these commercial roles he initiated innovative discovery deal structures with venture companies, research foundations and large integrated deals with pharmaceutical companies. Prior to Evotec, Cony worked at IGEN, Inc. where he was responsible for the marketing strategy of the life sciences division; in addition, he was involved in investor presentations and fund raising. Prior to IGEN Cony worked for Corning Inc. in the US and in Europe for twelve years. At Corning, he held a number of sales and marketing roles with increasing responsibility. In his last position Cony was responsible for marketing at a new business unit focused on high-throughput screening and molecular biology products. Cony received a BSc. in Applied Biology from the University of London and an MBA from The Open University, Milton Keynes UK.
Volker Eyrich, Vice President of Professional Solutions, joined Schrödinger in 2001. He received his Ph.D. in Physical Chemistry from Columbia University in 2000. In his graduate and post-doctoral research, he focused on the development of novel algorithms for ab initio protein folding simulations as well as large-scale benchmarking of protein structure prediction servers.
Leah Frye, Vice President of the Drug Discovery Group, joined Schrödinger in 2001. She received her Ph.D. in Synthetic Organic Chemistry from The Johns Hopkins University in 1984, and was an NIH NRSA Postdoctoral Fellow in the Department of Pharmacology and Experimental Therapeutics at The Johns Hopkins School of Medicine. Before joining Schrödinger, Leah was a Principal Scientist at Boehringer Ingelheim Pharmaceuticals and prior to that she was an Associate Professor of Chemistry at Rensselaer Polytechnic Institute.
Mathew D. Halls, Vice President of Materials Science, is responsible for leading the materials science program at Schrödinger. Prior to joining Schrödinger in 2012, he was a senior scientist and account manager at Materials Design, Inc. and Accelrys, Inc. Before that he held the prestigious E.R. Davidson Fellowship in theoretical chemistry at Indiana University and earlier was the Manager of the Scientific Simulation and Modeling Group at Zyvex Corporation. Mat has worked with Fortune 500 companies to advance the adoption of atomic-scale materials modeling techniques in diverse industries including aerospace, electronics and specialty chemicals. He has made significant research contributions in areas such as computational spectroscopy, organic optoelectronic materials, nanocarbon-polymer interfaces, thin-film precursors and deposition processes and battery electrolyte additives; with his work being cited more than 3000 times.
Shi-Yi Liu, Senior Vice President of Marketing, joined Schrödinger in 1997. She received her Ph.D. in Physical Chemistry from the University of Illinois in 1987. She worked at Allied-Signal as a computational chemist before becoming a founding member of the CAChe Group. In her position as Principal Chemist, she authored the molecular mechanics and molecular dynamics programs of CAChe Scientific. She holds an M.B.A. from the University of Oregon and a B.S. in Chemistry from the University of Washington.
Shunichi Ozawa, Vice President of Japan Operations, joined Schrödinger in 2011, and is Schrödinger KK's 代表取締役社長. Mr. Ozawais responsible for managing all of Schrödinger's operations in Japan. Prior to that, he was the lead salesperson of Schrödinger products for Infocom Corporation, Schrödinger's former exclusive distributor in Japan since 1997. Mr. Ozawa received a Bachelor of Science degree in Industrial Chemistry from Meiji University in 1996.
Murco Ringnalda, Chief Financial Officer, is a co-founder of Schrödinger, and was the first employee. He received his Ph.D. in Chemical Physics from the University of Texas at Austin in 1990. He was also a Research Fellow at Caltech prior to joining Schrödinger. He holds an M.B.A. from the University of Oregon and a B.A. from Reed College.
Yvonne Tran, Vice President and General Counsel, joined Schrödinger in 2010. Prior to joining Schrödinger, she served as Senior Corporate Counsel at Oracle America, Inc. and as Deputy General Counsel at DoubleClick Inc. As an in-house lawyer, she negotiated complex intellectual property and commercial transactions and provided legal support on M&A matters and intellectual property litigations. Yvonne worked at various law firms in New York immediately after law school, and her practice included intellectual property counseling and litigation. She has extensive experience in the software and technology services industries. Yvonne graduated from Yale in 1992 with a B.A. in Molecular Biophysics & Biochemistry and from the University of Virginia School of Law in 1995.
Jörg Weiser, Executive Vice President and Managing Director, Schrödinger GmbH, joined in 2002. He received his doctorate in Organic Chemistry from the Georg-August-University in Göttingen, Germany in 1996. He conducted post-doctoral research at Columbia University in New York from 1997 to 1999 and worked in the MacroModel team of Prof. Clark Still. He was co-founder and Managing Director of Anterio, a German consulting and research company established in 1999, prior to joining Schrödinger.